CN43 Maintaining intravenous anti-cancer systemic therapy during COVID: Pharmacy and nursing factors

Detalles Bibliográficos
Autores principales: O'Dwyer, R.T., Connolly, W., Hamilton, S., Kelly, S., Lynch, A., Martin, F., Dempsey, K., Rondthaler, A., Ryan, B., Byrne, A., Corrigan, R., Lawless, R., Conlon, L., Hickey, P., Manning, A., Egan, K., Breathnach, O.S., O'Shea, C., Christie, A., Treanor, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454362/
http://dx.doi.org/10.1016/j.annonc.2021.08.672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454362/
http://dx.doi.org/10.1016/j.annonc.2021.08.672

Ejemplares similares